
Join to View Full Profile
1 Dna Way Ms 454bSouth San Francisco, CA 94080
Dr. Ehrlich is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityResidency, Ophthalmology, 2005 - 2008
- Santa Clara Valley Medical CenterInternship, Transitional Year, 2004 - 2005
- Stanford University School of MedicineClass of 2004
Certifications & Licensure
- CA State Medical License 2005 - 2026
- American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- 115 citationsEfficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration: The STAIRWAY Phase 2 Randomized Clinic...Arshad M. Khanani, Sunil S. Patel, Philip J. Ferrone, Aaron Osborne, Jayashree Sahni
JAMA Ophthalmology. 2020-09-01 - 1 citationsRanibizumab in Diabetic Retinopathy with or without Diabetic Macular Edema.Andrew N. Antoszyk, Kathleen Wade Tarnowski, Karen Basu, Jason S. Ehrlich, Zdenka Haskova
Ophthalmology. Retina. 2020-06-05 - 2 citationsDiabetic Population-Based Model to Estimate Impact of Ranibizumab on Diabetic Retinopathy Severity in Patients with Diabetic Macular Edema.Rohit Varma, Neil M. Bressler, Quan V. Doan, Ivan J. Suñer, Mark D. Danese
Clinical Ophthalmology. 2020-05-07
Press Mentions
- SUBSPECIALTY NEWS: Port Drug Delivery in DME, Integrin Inhibitors, Treatment for XLRP, Eye Drops for DME, Gene Therapy, and MoreMarch 1st, 2020
- Kodiak Sciences Announces Additional Safety, Efficacy and Durability Data from Ongoing Phase 1b Study of KSI-301 in Patients with Wet Age-Related Macular Degeneration, Diabetic Macular Edema and R...February 8th, 2020
- SUBSPECIALTY NEWS: Stem-Cell Therapy for Geographic Atrophy, Artifacts in OCTA, European Opinion for Beovu, and MoreFebruary 1st, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: